Pilot and Feasibility Study Grants Program

试点和可行性研究赠款计划摘要 密歇根糖尿病转化研究中心（MCDTR）试点和可行性研究的目标 （P/FS）赠款计划旨在： ·鼓励新的研究人员进入2型糖尿病转化研究领域， 富有成效的合作， ·使获奖者能够生成足够的初步数据，以成功申请研究资助 从国家卫生研究院和其他国家授权机构，并公布他们的研究成果， ·加快将经证实有效的干预措施转化为现实世界医疗保健的步伐 环境、社区和高危人群。 每年，NIDDK授予MCDTR的50 000美元用于资助两项P/FS赠款。NIH基金 并视需要辅之以机构资金，以支持有价值的申请。P/FS赠款计划 促进征集、外部同行审查、内部审查和向获奖者分配资金， 规定监测支出和跟踪P/FS赠款，以评估由此产生的校外资金， 出版物。

Pilot and Feasibility Study Grants Program Abstract The goal of the Michigan Center for Diabetes Translational Research (MCDTR) Pilot and Feasibility Study (P/FS) Grants Program is to: • stimulate new investigators to enter the field of type 2 translational research in diabetes and to foster productive collaborations, • to enable awardees to generate sufficient preliminary data to successfully apply for research funding from the NIH and other national granting agencies and publish their research results, and • to accelerate the pace of translation of interventions with proven efficacy into real-world healthcare settings, communities, and populations at risk. Each year, $50,000 awarded to the MCDTR by NIDDK is used to fund two P/FS grants. NIH funds are supplemented with institutional funds as needed to support meritorious applications. The P/FS Grants program facilitates the solicitation, external peer-review, internal review, and distribution of funds to awardees, and provides for monitoring of expenditures and tracking of P/FS grants to assess resultant extramural funding and publications.